Physician

Imtiaz Khurshid, MD

According to 2025 Medicare claims, Imtiaz Khurshid, MD (NPI: 1740289917) practices pulmonary disease in the Hagerstown-Martinsburg, MD-WV market, with the plurality of this provider's patient population coming from Washington, MD. This provider's primary affiliated billing organization is MEDICAL PRACTICES OF ANTIETAM, LLC (NPI: 1558430843; TIN: 522315129) and primary practice location at 21742-2940. Khurshid is affiliated with the Loudoun Medical Group ACO LLC (ACO ID: A2189) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Khurshid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,301 traditional Medicare patients, billed 4,782 HCPCS/CPT codes, and received $284,132 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,381 prescription claims across 431 beneficiaries totaling $614,143 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 3,158 claims. Open Payments data shows 41 records totaling $1,454. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $16,954 to $284,132. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,845 to $614,143. For DME billing, reported payments rose steadily, from $8,375 to $116,269.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$186K$371K2016 Medicare payment: $16,954 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $46,485 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $172,882 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $371,499 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $317,116 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $315,415 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $313,864 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $264,387 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $284,132 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016115234$16,954
2017325698$46,485
20186771,748$172,882
20191,4244,421$371,499
20201,3403,826$317,116
20211,1113,784$315,415
20221,3063,829$313,864
20231,1683,611$264,387
20241,3014,782$284,132

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$307K$614K2016 Drug cost: $4,845 (USD; Tot_Drug_Cst)2017 Drug cost: $53,559 (USD; Tot_Drug_Cst)2018 Drug cost: $50,908 (USD; Tot_Drug_Cst)2019 Drug cost: $262,594 (USD; Tot_Drug_Cst)2020 Drug cost: $327,665 (USD; Tot_Drug_Cst)2021 Drug cost: $440,514 (USD; Tot_Drug_Cst)2022 Drug cost: $478,818 (USD; Tot_Drug_Cst)2023 Drug cost: $530,566 (USD; Tot_Drug_Cst)2024 Drug cost: $614,143 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161523$4,845
201764260$53,559
201888204$50,908
2019223732$262,594
20202521,030$327,665
20213121,227$440,514
20223721,518$478,818
20233761,854$530,566
20244312,381$614,143

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$74K$148K2015 Medicare payment: $4,178 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $20,635 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $40,236 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $87,373 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $127,793 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $148,305 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $139,165 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $133,692 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $107,481 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R76$4,178
2016N/RN/RN/R
2017301594$20,635
20185831,497$40,236
20199982,732$87,373
20201,2793,504$127,793
20211,3263,834$148,305
20221,3003,406$139,165
20231,1983,282$133,692
20241,1453,158$107,481

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more9391,457$91
94729Test to examine how well the lungs exchange gases238246$39
94727Test to determine lung volumes using gas dilution or washout228236$33
94060Test to measure expiratory airflow and volume changes before and after medication administration238246$27
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's7971,114$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29812,000$246,784
Breo ElliptaFluticasone/Vilanterol1104,110$51,721
Incruse ElliptaUmeclidinium Bromide1163,840$41,952
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr642,640$39,281
Stiolto RespimatTiotropium Br/Olodaterol Hcl652,484$37,366

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY44350$25,491
A7030Full face mask used with positive airway pressure device, eachN93185$15,382
A7031Face mask interface, replacement for full face mask, eachN80193$11,051
E0601Continuous positive airway pressure (cpap) deviceY63354$10,301
A7032Cushion for use on nasal mask interface, replacement only, eachN4496$6,519

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.41$1,454Olympus Corporation of the Americas
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Imtiaz Khurshid, MD?

Tedicare shows public-source Medicare data for Imtiaz Khurshid, MD (NPI 1740289917), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Imtiaz Khurshid, MD have ACO affiliation data?

Imtiaz Khurshid, MD is shown with ACO affiliation data for Loudoun Medical Group ACO LLC (MSSP, ACO ID A2189) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Imtiaz Khurshid, MD?

Imtiaz Khurshid, MD is linked to MEDICAL PRACTICES OF ANTIETAM, LLC (billing NPI 1558430843) in the available physician profile data.

Does Imtiaz Khurshid, MD have Open Payments data?

Imtiaz Khurshid, MD has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.